Michael Vance Molyneaux
Technik-/Wissenschafts-/F&E-Leiter bei Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd.
Vermögen: - $ am 30.04.2024
Profil
Michael Vance Molyneaux is currently the Executive Director & Chief Medical Officer at Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd.
He previously worked as the Medical Director at The Passavant Memorial Area Hospital Association from 2008 to 2013 and as the Chief Medical Officer at Macrocure Ltd.
(United States).
He also served as the Executive Director & Chief Medical Officer at Sirnaomics Ltd.
from 2021 to 2023.
Dr. Molyneaux holds a graduate degree from Washington University in St. Louis, a doctorate from Dalhousie University, and an undergraduate degree from the University of Prince Edward Island.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
SIRNAOMICS LTD.
-.--% | 30.11.2023 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von Michael Vance Molyneaux
Unternehmen | Position | Beginn |
---|---|---|
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd.
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sirnaomics, Inc., Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. is a Chinese company that develops nucleic acid drugs. The company is based in Suzhou, China. The company was founded in 2008 by Yang Lu, David Mark Evans. Yang Lu has been the CEO since 2008. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ehemalige bekannte Positionen von Michael Vance Molyneaux
Unternehmen | Position | Ende |
---|---|---|
SIRNAOMICS LTD. | Technik-/Wissenschafts-/F&E-Leiter | 30.11.2023 |
The Passavant Memorial Area Hospital Association
The Passavant Memorial Area Hospital Association Medical/Nursing ServicesHealth Services The Passavant Memorial Area Hospital Association provides health care services. Its services include surgery, behavioral health, cardiac, laboratory, wound care, telehealth, and rehabilitation. The company was founded in 1875 and is headquartered in Jacksonville, IL. | Corporate Officer/Principal | 01.01.2013 |
Macrocure Ltd. (United States) | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Michael Vance Molyneaux
Washington University in St. Louis | Graduate Degree |
Dalhousie University | Doctorate Degree |
University of Prince Edward Island | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
SIRNAOMICS LTD. | Health Technology |
Private Unternehmen | 3 |
---|---|
The Passavant Memorial Area Hospital Association
The Passavant Memorial Area Hospital Association Medical/Nursing ServicesHealth Services The Passavant Memorial Area Hospital Association provides health care services. Its services include surgery, behavioral health, cardiac, laboratory, wound care, telehealth, and rehabilitation. The company was founded in 1875 and is headquartered in Jacksonville, IL. | Health Services |
Macrocure Ltd. (United States) | |
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd.
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sirnaomics, Inc., Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. is a Chinese company that develops nucleic acid drugs. The company is based in Suzhou, China. The company was founded in 2008 by Yang Lu, David Mark Evans. Yang Lu has been the CEO since 2008. | Health Technology |